Literature DB >> 9885903

Inducible expression of nuclear factor IL-6 increases endogenous gene expression of macrophage inflammatory protein-1 alpha, osteopontin and CD14 in a monocytic leukemia cell line.

M Matsumoto1, Y Sakao, S Akira.   

Abstract

Nuclear factor-IL-6 (NF-IL6) belongs to the CCAAT/enhancer binding protein family of transcription factors. NF-IL6 binds to the regulatory regions of many genes induced in activated macrophages in vitro. However, which particular genes are regulated by NF-IL6 in vivo is poorly defined. In order to identify the downstream genes of NF-IL6 in a monocytic lineage, we combined an inducible expression system with subtraction cloning in a study of murine M1 monocytic leukemia cells. We demonstrated that inducible expression of NF-IL6 is able to increase endogenous gene expression of macrophage inflammatory protein (MIP)-1 alpha, osteopontin and CD14 in M1 cells. We also showed that NF-IL6 activated murine MIP-1 alpha proximal promoter luciferase construct which contains two NF-IL6 binding sites and a point mutation of either site markedly reduces the luciferase activity. These findings indicate that MIP-1 alpha is a direct target of NF-IL6.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9885903     DOI: 10.1093/intimm/10.12.1825

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  9 in total

1.  TIF1beta functions as a coactivator for C/EBPbeta and is required for induced differentiation in the myelomonocytic cell line U937.

Authors:  J W Rooney; K L Calame
Journal:  Genes Dev       Date:  2001-11-15       Impact factor: 11.361

2.  Elevated myocardial Na+/H+ exchanger isoform 1 activity elicits gene expression that leads to cardiac hypertrophy.

Authors:  Jin Xue; Fatima Mraiche; Dan Zhou; Morris Karmazyn; Tatsujiro Oka; Larry Fliegel; Gabriel G Haddad
Journal:  Physiol Genomics       Date:  2010-05-11       Impact factor: 3.107

3.  Conditional expression of liver-enriched transcriptional activator protein augments Acholeplasma laidlawii-induced granulysin gene expression in a human monocytic cell line, THP-1.

Authors:  Yutaka Kida; Takashi Shimizu; Koichi Kuwano
Journal:  Immunology       Date:  2005-01       Impact factor: 7.397

4.  Transcriptional regulation of the human MIP-1alpha promoter by RUNX1 and MOZ.

Authors:  Claire A P Bristow; Paul Shore
Journal:  Nucleic Acids Res       Date:  2003-06-01       Impact factor: 16.971

5.  Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes.

Authors:  David B Rozema; David L Lewis; Darren H Wakefield; So C Wong; Jason J Klein; Paula L Roesch; Stephanie L Bertin; Tom W Reppen; Qili Chu; Andrei V Blokhin; James E Hagstrom; Jon A Wolff
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-24       Impact factor: 11.205

6.  The inflammation-related gene S100A12 is positively regulated by C/EBPβ and AP-1 in pigs.

Authors:  Xinyun Li; Juan Tang; Jing Xu; Mengjin Zhu; Jianhua Cao; Ying Liu; Mei Yu; Shuhong Zhao
Journal:  Int J Mol Sci       Date:  2014-08-08       Impact factor: 5.923

Review 7.  CCAAT/enhancer binding protein β in relation to ER stress, inflammation, and metabolic disturbances.

Authors:  Sophie E van der Krieken; Herman E Popeijus; Ronald P Mensink; Jogchum Plat
Journal:  Biomed Res Int       Date:  2015-01-28       Impact factor: 3.411

8.  Inhibition of the CEBPβ-NFκB interaction by nanocarrier-packaged Carnosic acid ameliorates glia-mediated neuroinflammation and improves cognitive function in an Alzheimer's disease model.

Authors:  Wang Yi-Bin; Li Xiang; Yang Bing; Zhang Qi; Jiao Fei-Tong; Wang Minghong; Zhang Xiangxiang; Kang Le; Li Yan; Sui Ping; Gao Yufei; Xu Ye; Wang Chun-Yan
Journal:  Cell Death Dis       Date:  2022-04-07       Impact factor: 8.469

9.  Analysis of Il36a induction by C/EBPβ via a half-CRE•C/EBP element in murine macrophages in dependence of its CpG methylation level.

Authors:  Andreas Nerlich; Nina Janze; Ralph Goethe
Journal:  Genes Immun       Date:  2021-10-25       Impact factor: 2.676

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.